Vascular pleiosynergy--does it really work?

Albert Császár1

  • 1Department of Medicine, National Health Center, Budapest, Hungary. csaszalb@ogyik.hu

Insights

Multiple cardiovascular risk factors amplify risk, but combined treatments multiply benefits. Some drugs offer additional advantages through pleiotropic effects, a phenomenon termed pleiosynergy, enhancing therapeutic outcomes.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Molecular Biology

Background:

  • Cardiovascular disease risk escalates with multiple contributing factors.
  • Simultaneous treatment of these factors can yield synergistic therapeutic benefits.
  • Certain medications possess pleiotropic effects extending beyond their primary therapeutic actions.

Purpose of the Study:

  • To define and explore the concept of pleiosynergy in pharmacology.
  • To investigate pleiotropic effects of lipid-lowering statins and third-generation calcium channel blockers.
  • To understand how these additional effects contribute to overall cardiovascular health.

Main Methods:

  • Literature review of studies on statins and calcium channel blockers.
  • Analysis of reported pleiotropic mechanisms, including nitric oxide (NO) production, antioxidant activity, and smooth muscle cell modulation.
  • Conceptual framework development for pleiosynergy.

Main Results:

  • Statins and third-generation calcium channel blockers exhibit significant pleiotropic effects.
  • These effects include enhanced endothelial nitric oxide (NO) production, reduced free radical formation, and inhibition of smooth muscle cell migration and proliferation.
  • These additional actions are independent of the drugs' primary lipid-lowering or blood pressure-reducing effects.

Conclusions:

  • Pleiotropic effects of cardiovascular drugs can lead to 'therapeutic cross effects'.
  • This phenomenon, defined as pleiosynergy, enhances overall treatment efficacy.
  • Understanding pleiosynergy offers new perspectives for cardiovascular drug development and combination therapy.

Related Concept Videos

Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Cytoskeletal Accessory Proteins01:13

Cytoskeletal Accessory Proteins

The cytoskeleton is an essential cell component that plays several structural and functional roles. However, the filaments that make up the cytoskeleton cannot function independently and depend on the accessory or ancillary proteins to effectively carry out their function. Accessory proteins associate with cytoskeletal filaments and their monomers, aiding filament formation and function. They also help in the cross-communication among cytoskeletal filaments. Cytoskeletal accessory proteins are...
Sympathetic Activation01:16

Sympathetic Activation

The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...